KMPR News 38.99 Unitrin (KMPR)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Unitrin (KMPR) 38.99 $KMPR

Kemper Corporation Announces Schedule for First Quarter Earnings Call
Business Wire - Thu Apr 10, 2:46PM CDT
Kemper Corporation (NYSE: KMPR) announced today that it will host its conference call to discuss first quarter 2014 results on Friday, May 9, 2014 at 11:00 a.m. Eastern (10:00 a.m. Central).

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Moody's Ups View on MetLife's Long-Term Debt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 4:43PM CDT
MetLife's strong ratings were further boosted by a lift in the outlook from Moody's Investor Service.

Balanced View On Prudential Financial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 2:30PM CDT
On April 4, 2014, we issued an updated research report on Prudential Financial, Inc.

Prudential Targets Dutch Property Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 1:40PM CDT
In an effort to reap benefits from the underfunding in the Dutch lending market, Prudential Real Estate Investors, has launched a debt vehicle with Algemene Pensioen Groep (APG).

Cigna Corp. (CI) in Focus: Stock Moves 5.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 8:18AM CDT
Cigna Corp. (CI) was a big mover last session, as the company saw its shares rise by over 5% on the day.

Updated Research Report on AIG - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 1:16PM CDT
On March 26, 2014, we issued an updated research report on AIG.

MGIC Investment Upgraded to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 11:50AM CDT
On Mar 26, 2014, Zacks Investment Research upgraded MGIC Investment Corp. to a Zacks Rank #1 (Strong Buy).

Cigna Downgraded to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 2:20PM CDT
On Mar 25, Zacks Investment Research downgraded U.S. health insurer Cigna to a Zacks Rank #4 (Sell).

Why the Earnings Streak Will Continue for Kemper (KMPR) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:44AM CDT
Kemper could be a great candidate to beat earnings at its next report

Assurant Strikes 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:00PM CDT
Assurant's shares hit a 52-week high of $69.12, the momentum in the stock led by solid performance.

Global Payments Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 2:30PM CST
Riding on a steady growth momentum, shares of Global Payments Inc. reached a new 52-week high of $72.04 on Mar 6.

Kemper Management to Speak at New York Society of Securities Analysts 18th Annual Insurance Conference
Business Wire - Wed Mar 05, 10:39AM CST
Kemper Corporation (NYSE: KMPR) announced today that Frank J. Sodaro, Kemper's Senior Vice President and Chief Financial Officer, will speak at the New York Society of Securities Analysts 18th Annual Insurance Conference on Tuesday, March 18, 2014 at 1:00 p.m. Eastern time. The presentation will be webcast live on the investors section of Kemper's website, and available on an archived basis. To listen via webcast, register online at the investor section of kemper.com at least 15 minutes prior to the webcast to download and install any necessary software.

A.M. Best Assigns Debt Rating to Kemper Corporation's Newly Issued Subordinated Debentures
Business Wire - Fri Feb 28, 9:45AM CST
A.M. Best has assigned a debt rating of "bb+" to the recently issued $150.0 million 7.375% subordinated debentures due 2054 of Kemper Corporation (Kemper) (Chicago, IL) [NYSE: KMPR]. Concurrently, A.M. Best has assigned indicative ratings of "bbb-" to senior debt, "bb+" to subordinated debt and "bb" to preferred stock of Kemper's recently filed shelf registration. The outlook assigned to all ratings is stable.

Assured Guaranty Earnings & Revs Top Ests in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 12:00PM CST
Assured Guaranty delivered operating net income of 73 cents per share in the fourth-quarter of 2013, surpassing the Zacks Consensus Estimate of 66 cents by 10.6%

Why Kemper (KMPR) Could Be a Top Value Stock Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 7:42AM CST
Kemper is a value stock for investors and is poised to outperform based on its PE below 20, a P/S ratio below one,a strong Zacks Rank and solid activity on the earnings estimate front as well.

Cigna, PremierCare Northwest Form ACO - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 5:39PM CST
Continuing with the strategy to enhance its CAC initiative, health insurer Cigna has tied up with PremierCare Northwest in Arkansas.

Kemper prices USD150m subordinated debenture offering
M2 - Fri Feb 21, 5:58AM CST
US-based diversified insurance holding company, Kemper Corporation (NYSE:KMPR) priced a registered offering of USD150m of 7.375% subordinated debentures due 2054, it said on Thursday.

Fitch Expects to Rate Kemper's Subordinated Debentures 'BB'
Business Wire - Thu Feb 20, 5:33PM CST
Fitch Ratings expects to assign a 'BB' rating to Kemper Corporation's (Kemper) $150 million issuance of cumulative subordinated debentures maturing in 2054.

Kemper Corporation Prices $150 Million Subordinated Debenture Offering
Business Wire - Thu Feb 20, 4:01PM CST
Kemper Corporation (NYSE: KMPR) announced that it has priced a registered offering of $150 million of 7.375% subordinated debentures due 2054. Kemper intends to use the net proceeds from this offering for working capital and other general corporate purposes, which may include retirement of a portion of its existing debt on or before its scheduled maturity date.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 34

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 37

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 184

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
MatterSeek Platform Revolutionizing Materials R&D Worldwide

Updated Category News Views 39

Innovating the R&D Landscape with MatterSeek In the ever-changing realm of materials research and development, Yuyao Technology's latest innovation, MatterSeek, is a game changer. It's a slick launch, folks, redefining how we look at the R&D landscape through its AI-driven abilities. This ain't just another pie-in-the-sky platform; it's an actual workhorse designed to...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 122

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 280

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 22

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 75

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 111

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

Luckbox Stock Reaches New Low: Market Movements Explained

Updated Category News Views 326

Luckbox Stock Performance Overview The gaming and esports betting company, Luckbox, is currently navigating a fluctuating market landscape, with its stock price recently dipping to a notable 52-week low of $9.68. This shift is a pronounced departure from the previous year, reflecting ongoing challenges within the industry. As of now, the company's market capitalization...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 153

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Mirum Pharmaceuticals Presents Promising LIVMARLI Data at Conference

Updated Category News Views 107

Mirum Pharmaceuticals showcases LIVMARLI research findings Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has announced its participation in a significant scientific meeting where it aims to present groundbreaking data on LIVMARLI® (maralixibat) oral solution. This event is hosted by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition...

Continue Reading
Genmab Stock Faces Challenges, Yet Holds Hope for Recovery

Updated Category News Views 130

Genmab Stock Overview Genmab A/S Sponsored ADR (NASDAQ: GMAB) has recently experienced a turbulent period, with a notable decline of 14.7% in just four weeks. However, this decline has left the stock in an oversold position, igniting hope among investors as analysts anticipate improved earnings results. Understanding Oversold Conditions To assess whether a stock, such as...

Continue Reading
Challenges Ahead for Central Banks Tackling Inflation Variability

Updated Category News Views 117

Challenges Ahead for Central Banks in Addressing Inflation Fluctuations Inflation is a complex issue for policymakers, as recent comments from European Central Bank President Christine Lagarde illustrate. With substantial changes happening in the global economy, the prospect of stable inflation remains uncertain. Lagarde suggests that inflation may experience significant...

Continue Reading